Avacta Group plc (AIM: AVCT), the developer of diagnostics and innovative cancer therapies based on its proprietary Affimer® and pre|CISION™ platforms, is pleased to announce positive data from the clinical validation of its AffiDX® SARS-CoV-2 antigen lateral flow test. Data from the clinical study conducted in Europe on 98 positive COVID-19 samples demonstrate excellent performance in...
Zyme Communications
Zyme Communications provides PR and marketing services for the life science sector. We support companies to raise their profile, build corporate value and generate interest from commercial leads, investors and partners.
Telephone: +44 (0)1223 968 920
Address :
Stirling House, Cambridge Innovation Park, Denny End Road, Waterbeach, Cambridge
Post Code: CB25 9QE
Country: United Kingdom
Website: http://zymecommunications.com
Membership Type: Corporate 6-20
There are no Products & Services to display
20-04-2021
CRISPR offerings to enhance NUVISAN’s drug development service portfolio.
19-04-2021
London, UK... Adaptate Biotherapeutics, a company focused on developing antibody-based therapeutics for modulation of gamma delta T cells, today announced that its existing investors, Abingworth and Takeda Pharmaceutical Company Limited have together made a further equity investment of $18 million (circa. £13 million). This funding brings the total raised since Adaptate’s inception in late...
19-04-2021
Bishop’s Stortford, UK: Dotmatics Ltd, a scientific informatics software and services company that is driving the automation of laboratory data workflows for scientific discovery and innovation research, today announced it has been selected by Arkema, a global leader in speciality materials, as its informatics partner in an R&D digitalization project. Implementing Dotmatics’ unified...
13-04-2021
Porto, Portugal, and Cambridge and London, UK: FairJourney Biologics S.A (FJB) and IONTAS Limited (IONTAS), leaders in the discovery and optimisation of VHH fully human antibodies, today announced a collaboration with global immunology company, argenx to harness IONTAS’ proprietary mammalian display technology. The goal of the collaboration is to explore diverse panels of novel antibody...
12-04-2021
Mologic, a leading developer of lateral flow and rapid diagnostic technologies, announced its rapid antigen self-test for COVID-19 has been selected by the Rapid Acceleration of Diagnostics (RADxSM) initiative launched by the US National Institutes of Health (NIH). The initiative aims to speed innovation in the development, commercialisation, and implementation of technologies for COVID-19...
07-04-2021
Avacta Group plc (AIM: AVCT), the developer of innovative cancer therapies and diagnostics based on its proprietary Affimer® and pre|CISION™ platforms, is pleased to announce that it has entered into a global distribution agreement with Abcam plc (AIM: ABC; NASDAQ: ABCM) to sell the Group’s recently developed SARS-CoV-2 research ELISA Affimer® reagents.
06-04-2021
Dotmatics Ltd, a scientific informatics software and services company that is driving the automation of laboratory data workflows for scientific discovery and innovation research, today announced the implementation of a ‘Data to Value’ initiative with BASF’s Agricultural Solutions division.
31-03-2021
Bishop’s Stortford, UK and San Diego, CA— Insightful Science, a leading software provider serving the global life sciences community, announced that it has entered into a transaction to acquire Dotmatics, an industry leading cloud-based scientific R&D data management platform.
23-03-2021
PhoreMost Ltd, the UK-based biopharmaceutical company dedicated to ‘Drugging the Undruggable®’ disease targets, today announced it has completed an oversubscribed £33m ($46m) Series B investment round. The round was led by BGF, the UK’s most active growth economy investor, and included new investors XtalPi Inc., Astellas Venture Management, Trend Investment Group, and o2h ventures. Existing...
23-03-2021
Cambridge, UK, Porto, Portugal, and London, UK – IONTAS Limited and FairJourney Biologics SA (FJB), leaders in the discovery and optimisation of fully human antibodies, have announced the identification of neutralising antibodies, which bind to multiple emerging SARS-CoV-2 variants.
22-03-2021
York and Bedfordshire, UK...Aptamer Group, the developer of diagnostic and therapeuticOptimer reagents, today announced a commercial partnership with Mologic, a leading developer and manufacturer of lateral flow and rapid diagnostic tests.
19-03-2021
Axol Bioscience Ltd, an established provider of iPSC-derived cells, media, and characterisation services, and CENSO Biotechnologies, a cell biology CRO with focused expertise in iPSC-related technologies, today announced that the two companies have signed a merger agreement.
17-03-2021
Nobel prize winning CRISPR technology to be applied in development of genetically engineered cell and animal models.
10-03-2021
Avacta’s AffiDX SARS-CoV-2 lateral flow test detects both B117 ‘Kent’ and D614G variants of the virus.
08-03-2021
Birmingham, UK: Nonacus, a provider of genetic testing products for precision medicine and liquid biopsy, today announced the commercial launch of a new service for Whole Genome Sequencing of SARS-CoV-2, developed to enable the UK government’s Test-To-Release scheme. Assay development for the new service was funded by a grant from Innovate UK, the UK’s innovation agency.
08-03-2021
Cambridge, UK, Porto, Portugal, and London, UK – 08 March 2021: IONTAS Limited and FairJourney Biologics S.A (FJB)., leaders in the discovery and optimisation of fully human antibodies, have announced that they have entered into an agreement with Quell Therapeutics Limited regarding IONTAS / FJB’s proprietary libraries and technology platforms.
08-03-2021
PHILADELPHIA and OXFORD, March 2, 2021 - WuXi AppTec, a leading global provider of R&D- and manufacturing-enabling services in the pharmaceutical, biotechnology and medical device industries, today announced that it has completed the acquisition of OXGENE, a pioneering United Kingdom-based contract research and development organization that designs and develops scalable gene therapy...
03-03-2021
Licence to Nobel prize winning CRISPR technology supports internal research and development.
03-03-2021
Bishop’s Stortford, UK, 3rd March 2021: Dotmatics Ltd, a scientific informatics software and services company that is driving the automation of laboratory data workflows for scientific discovery and innovation research, today announced it has entered a licensing agreement with Compugen, a clinical-stage drug discovery and development company focused on immuno-oncology. The multi-year agreement...
03-03-2021
Pages
There are no events to display
20/04/2021
PR and Marketing Manager
As PR and Marketing Manager you will be part of the Zyme Communications (Zyme) team and will manage client accounts and...
Location: Cambridge
Salary Range:
Competitive
20/04/2021
PR and Marketing Executive
As PR and Marketing Executive you will be providing support across Zyme Communications (Zyme) clients. You will be part of...
Location: Cambridge
Salary Range:
Competitive
No Blog articles found
